News

Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate ...
While multiple machine learning (ML) algorithms offered similar predictive performance, the cost-effective analysis revealed ...
The least absolute shrinkage and selection operator-logistic regression (Lasso-LR) model is optimal for predicting ...
Tesla's most affordable offering, the Model 3, is finally getting an update for the first time since its 2017 introduction. Dubbed project "Highland," the update aims to reduce production costs ...
Study design of the German Society of Pediatric Oncology and Hematology Hodgkin Lymphoma Trial 95 ... in univariate and multivariate analyses using the Cox regression model. 13 The cutoff for data ...
A handful of people make up the core of your care team. You will have a hematologist-oncologist and a registered nurse who are experienced in caring for people with Hodgkin lymphoma. At some visits, ...
Meraki Global Advisors ("Meraki"), a leading provider of institutional-grade outsourced trading through its Integrated Trade ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Meta is delaying the release of its most ambitious large language model, codenamed Behemoth, in what insiders describe as a moment of reckoning for the company’s massive artificial intelligence ...
DeepSeek stunned the AI industry when it unveiled its flagship model R1 earlier this year. Microsoft CEO Satya Nadella said R1 was the first model he had seen that could match up to OpenAI's.